These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27087149)

  • 1. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate.
    Graves SF; Kouriba B; Diarra I; Daou M; Niangaly A; Coulibaly D; Keita Y; Laurens MB; Berry AA; Vekemans J; Ripley Ballou W; Lanar DE; Dutta S; Gray Heppner D; Soisson L; Diggs CL; Thera MA; Doumbo OK; Plowe CV; Sztein MB; Lyke KE
    Vaccine; 2016 May; 34(23):2546-55. PubMed ID: 27087149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.
    Thera MA; Doumbo OK; Coulibaly D; Laurens MB; Kone AK; Guindo AB; Traore K; Sissoko M; Diallo DA; Diarra I; Kouriba B; Daou M; Dolo A; Baby M; Sissoko MS; Sagara I; Niangaly A; Traore I; Olotu A; Godeaux O; Leach A; Dubois MC; Ballou WR; Cohen J; Thompson D; Dube T; Soisson L; Diggs CL; Takala SL; Lyke KE; House B; Lanar DE; Dutta S; Heppner DG; Plowe CV
    PLoS One; 2010 Feb; 5(2):e9041. PubMed ID: 20140214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
    Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
    Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    Laurens MB; Kouriba B; Bergmann-Leitner E; Angov E; Coulibaly D; Diarra I; Daou M; Niangaly A; Blackwelder WC; Wu Y; Cohen J; Ballou WR; Vekemans J; Lanar DE; Dutta S; Diggs C; Soisson L; Heppner DG; Doumbo OK; Plowe CV; Thera MA
    PLoS One; 2017; 12(3):e0173294. PubMed ID: 28282396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02
    Ouattara A; Niangaly A; Adams M; Coulibaly D; Kone AK; Traore K; Laurens MB; Tolo Y; Kouriba B; Diallo DA; Doumbo OK; Plowe CV; Djimdé A; Thera MA; Laufer MK; Takala-Harrison S; Silva JC
    Vaccine; 2020 Jul; 38(35):5700-5706. PubMed ID: 32571720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells.
    Huaman MC; Mullen GE; Long CA; Mahanty S
    Vaccine; 2009 Aug; 27(38):5239-46. PubMed ID: 19591795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.
    Laurens MB; Thera MA; Coulibaly D; Ouattara A; Kone AK; Guindo AB; Traore K; Traore I; Kouriba B; Diallo DA; Diarra I; Daou M; Dolo A; Tolo Y; Sissoko MS; Niangaly A; Sissoko M; Takala-Harrison S; Lyke KE; Wu Y; Blackwelder WC; Godeaux O; Vekemans J; Dubois MC; Ballou WR; Cohen J; Dube T; Soisson L; Diggs CL; House B; Bennett JW; Lanar DE; Dutta S; Heppner DG; Plowe CV; Doumbo OK
    PLoS One; 2013; 8(11):e79323. PubMed ID: 24260195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
    Ouattara A; Takala-Harrison S; Thera MA; Coulibaly D; Niangaly A; Saye R; Tolo Y; Dutta S; Heppner DG; Soisson L; Diggs CL; Vekemans J; Cohen J; Blackwelder WC; Dube T; Laurens MB; Doumbo OK; Plowe CV
    J Infect Dis; 2013 Feb; 207(3):511-9. PubMed ID: 23204168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
    Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
    Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
    Sedegah M; Hollingdale MR; Farooq F; Ganeshan H; Belmonte M; Kim Y; Peters B; Sette A; Huang J; McGrath S; Abot E; Limbach K; Shi M; Soisson L; Diggs C; Chuang I; Tamminga C; Epstein JE; Villasante E; Richie TL
    PLoS One; 2014; 9(9):e106241. PubMed ID: 25211344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.
    Thera MA; Doumbo OK; Coulibaly D; Diallo DA; Kone AK; Guindo AB; Traore K; Dicko A; Sagara I; Sissoko MS; Baby M; Sissoko M; Diarra I; Niangaly A; Dolo A; Daou M; Diawara SI; Heppner DG; Stewart VA; Angov E; Bergmann-Leitner ES; Lanar DE; Dutta S; Soisson L; Diggs CL; Leach A; Owusu A; Dubois MC; Cohen J; Nixon JN; Gregson A; Takala SL; Lyke KE; Plowe CV
    PLoS One; 2008 Jan; 3(1):e1465. PubMed ID: 18213374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine.
    Ouattara A; Mu J; Takala-Harrison S; Saye R; Sagara I; Dicko A; Niangaly A; Duan J; Ellis RD; Miller LH; Su XZ; Plowe CV; Doumbo OK
    Malar J; 2010 Jun; 9():175. PubMed ID: 20565971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
    Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
    PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial.
    Lyke KE; Daou M; Diarra I; Kone A; Kouriba B; Thera MA; Dutta S; Lanar DE; Heppner DG; Doumbo OK; Plowe CV; Sztein MB
    Vaccine; 2009 Mar; 27(15):2171-6. PubMed ID: 19356621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field trial to assess a blood-stage malaria vaccine.
    Thera MA; Doumbo OK; Coulibaly D; Laurens MB; Ouattara A; Kone AK; Guindo AB; Traore K; Traore I; Kouriba B; Diallo DA; Diarra I; Daou M; Dolo A; Tolo Y; Sissoko MS; Niangaly A; Sissoko M; Takala-Harrison S; Lyke KE; Wu Y; Blackwelder WC; Godeaux O; Vekemans J; Dubois MC; Ballou WR; Cohen J; Thompson D; Dube T; Soisson L; Diggs CL; House B; Lanar DE; Dutta S; Heppner DG; Plowe CV
    N Engl J Med; 2011 Sep; 365(11):1004-13. PubMed ID: 21916638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
    Tamminga C; Sedegah M; Maiolatesi S; Fedders C; Reyes S; Reyes A; Vasquez C; Alcorta Y; Chuang I; Spring M; Kavanaugh M; Ganeshan H; Huang J; Belmonte M; Abot E; Belmonte A; Banania J; Farooq F; Murphy J; Komisar J; Richie NO; Bennett J; Limbach K; Patterson NB; Bruder JT; Shi M; Miller E; Dutta S; Diggs C; Soisson LA; Hollingdale MR; Epstein JE; Richie TL
    Hum Vaccin Immunother; 2013 Oct; 9(10):2165-77. PubMed ID: 23899517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
    Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
    Sirima SB; Durier C; Kara L; Houard S; Gansane A; Loulergue P; Bahuaud M; Benhamouda N; Nebié I; Faber B; Remarque E; Launay O;
    Vaccine; 2017 Oct; 35(45):6218-6227. PubMed ID: 28947345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.
    Sedegah M; Tamminga C; McGrath S; House B; Ganeshan H; Lejano J; Abot E; Banania GJ; Sayo R; Farooq F; Belmonte M; Manohar N; Richie NO; Wood C; Long CA; Regis D; Williams FT; Shi M; Chuang I; Spring M; Epstein JE; Mendoza-Silveiras J; Limbach K; Patterson NB; Bruder JT; Doolan DL; King CR; Soisson L; Diggs C; Carucci D; Dutta S; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2011; 6(10):e24586. PubMed ID: 22003383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.